Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianda Pharmaceuticals Ltd (455) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14756
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic areas such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory drugs, anti-infective drugs, anti-diabetic drugs, anti-neoplastics drugs and detoxification drugs. Its cardio-cerebrovascular drugs comprise zhikang granules, cerebroprotein hydrolysate injection, valsartan capsules, aceglutamide injection, vinpocetine injection and aspirin enteric-coated tablets. Tianda Pharma also conducts research and development for vaccines and blood products. The company operates two research and development centers and production bases in Zhuhai and Kunming, China. It has operations in China and Australia. Tianda Pharma is headquartered in Hong Kong.

Tianda Pharmaceuticals Ltd Key Recent Developments

Dec 04,2018: Tianda Pharmaceuticals 2018 interim results
Jun 28,2018: Tianda Pharmaceuticals: Annual Results Announcement for the Year Ended 31 March 2018

This comprehensive SWOT profile of Tianda Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianda Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianda Pharmaceuticals Ltd – Key Information
Tianda Pharmaceuticals Ltd – Overview
Tianda Pharmaceuticals Ltd – Key Employees
Tianda Pharmaceuticals Ltd – Key Employee Biographies
Tianda Pharmaceuticals Ltd – Key Operational Heads
Tianda Pharmaceuticals Ltd – Major Products and Services
Tianda Pharmaceuticals Ltd – History
Tianda Pharmaceuticals Ltd – Company Statement
Tianda Pharmaceuticals Ltd – Locations And Subsidiaries
Tianda Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianda Pharmaceuticals Ltd – Business Description
Tianda Pharmaceuticals Ltd – Corporate Strategy
Tianda Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianda Pharmaceuticals Ltd – Strengths
Tianda Pharmaceuticals Ltd – Weaknesses
Tianda Pharmaceuticals Ltd – Opportunities
Tianda Pharmaceuticals Ltd – Threats
Tianda Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianda Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianda Pharmaceuticals Ltd, Key Information
Tianda Pharmaceuticals Ltd, Key Ratios
Tianda Pharmaceuticals Ltd, Share Data
Tianda Pharmaceuticals Ltd, Major Products and Services
Tianda Pharmaceuticals Ltd, History
Tianda Pharmaceuticals Ltd, Key Employees
Tianda Pharmaceuticals Ltd, Key Employee Biographies
Tianda Pharmaceuticals Ltd, Key Operational Heads
Tianda Pharmaceuticals Ltd, Other Locations
Tianda Pharmaceuticals Ltd, Subsidiaries
Tianda Pharmaceuticals Ltd, Key Manufacturing facilities
Tianda Pharmaceuticals Ltd, Key Competitors
Tianda Pharmaceuticals Ltd, SWOT Analysis
Tianda Pharmaceuticals Ltd, Ratios based on current share price
Tianda Pharmaceuticals Ltd, Annual Ratios
Tianda Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Tianda Pharmaceuticals Ltd, Performance Chart
Tianda Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JX Nippon Oil & Energy Corporation-石油・ガス分野:企業M&A・提携分析
    Summary JX Nippon Oil & Energy Corporation (JXNOE) is a downstream refining company. The company refines and markets petroleum and petrochemical products. Its products include petrochemicals, lubricants, optical films, greases, fluids, engine oils, composites, Panaferd-AX, Tow PREPREG, sheet pallet …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Talisman Mining Ltd (TLM):企業の財務・戦略的SWOT分析
    Summary Talisman Mining Ltd (Talisman Mining) is a mining and mineral exploration and development company. The company explores for copper-gold, base metal, and gold deposits. Its projects portfolio includes Springfield project, Sinclair Nickel Project, Milgun Project, Halloween and Halloween West J …
  • One Way Liver SL:医療機器:M&Aディール及び事業提携情報
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that develops, discovers, and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver that is a serum based test used for steatosis and NASH diagno …
  • High Peak Royalties Ltd (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務情報
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Linde AG (LIN)-製薬・医療分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • Modern India Ltd:企業の戦略・SWOT・財務情報
    Modern India Ltd - Strategy, SWOT and Corporate Finance Report Summary Modern India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Konsortium Transnasional Berhad:企業の戦略・SWOT・財務情報
    Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Teachers Mutual Bank Ltd:企業の戦略的SWOT分析
    Teachers Mutual Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Arthrex Inc-医療機器分野:企業M&A・提携分析
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company which designs, and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • VAALCO Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    VAALCO Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary VAALCO Energy, Inc. (VAALCO) is an upstream oil and gas company. It acquires, explores, develops and produces crude oil and natural gas from assets. The company conducts the exploration activities …
  • SoftBank Group Corporation:企業のM&A・事業提携・投資動向
    SoftBank Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SoftBank Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Vaxart Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaxart Inc (Vaxart) focuses on the development of recombinant vaccines based on its proprietary oral vaccine delivery platform. The company is currently developing tablet vaccines for seasonal and pandemic influenza, norovirus, and Respiratory Syncytial Virus (RSV). Vaxart’s vaccine delivery …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆